First Patent for Translation Risk Management Awarded to Crimson Life Sciences
4/18/2012 9:53:50 AM
BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--Crimson Life Sciences, a division of TransPerfect and the only ISO 13485 and ISO 14971 certified translation provider, was recently granted the world’s first translation risk management patent (U.S. Patent No. 8,140,322 B2). Invented by Kai Simonsen, Crimson’s VP of Production & Quality Systems, and Marc H. Miller, Division President, the Crimson patent provides a valuable advancement to “state of the art” that device makers can use to demonstrate compliance and satisfy key risk management requirements for translated labeling.